Bonumose offers Tagatose, a rare sugar with dental and oral microbiome benefits, for formulation incorporation. Validated as a sugar replacement, it promotes beneficial bacteria and is ready for commercial use.
Tagatose, offered by Bonumose, is a groundbreaking rare sugar that promises significant benefits for dental health and the oral microbiome. Unlike conventional sugars, Tagatose not only mimics the taste of sugar but also plays a protective role in oral health by fostering beneficial bacteria. It serves as an innovative alternative to xylitol, providing an opportunity for formulators to enhance the health profile of their products while maintaining desirable sweetness.
Key features:
Tagatose from Bonumose has achieved a Technology Readiness Level of 9, indicating it is fully validated and ready for widespread commercial application. Bonumose is prepared to supply Tagatose to interested partners for integration into their product formulations, supported by extensive literature and existing partnerships with industry leaders.
Bonumose is a startup specializing in innovative carbohydrate ingredients. It pioneered the affordable Tagatose production method and has built partnerships with food industry giants to bring rare sugars like Tagatose and Allulose into mainstream use for healthier foods.